• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Galena Biopharma Inc

+ Add to Watchlist

GALE:US

2.8900 USD 0.0800 2.85%

As of 14:38:11 ET on 07/11/2014.

Snapshot for Galena Biopharma Inc (GALE)

Open: 2.8100 Day's Range: 2.8000 - 2.9200 Volume: 749,529
Previous Close: 2.8100 52wk Range: 1.6500 - 7.7700 1-Yr Rtn: +50.52%

Stock Chart for GALE

No chart data available.
  • GALE:US 2.8899
  • 1D
  • 1M
  • 1Y
2.8100
Interactive GALE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GALE

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.7281
Est. EPS (USD) (12/2014) -0.3010
Est. PEG Ratio -
Market Cap (M USD) 337.64
Shares Outstanding (M) 118.03
30 Day Average Volume 4,246,211
Price/Book (mrq) 7.3347
Price/Sale (ttm) 65.0060
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GALE

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for GALE

Galena Biopharma, Inc. is a biopharmaceuticals company that develops late-stage oncology drugs. The Company develops therapies that activate cells in the immune system to seek out and eliminate tumor cells without harming healthy tissue.

Mark J AhnPresident/CEOMark W SchwartzExec VP/COO
Brian L HamiltonExec VP/Chief Medical OfficerRyan M DunlapVP/CFO/Secretary
More Company Profile & Key Executives for GALE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil